Volume 20, Issue 7
Medication Safety Alert! July 2021
In this month's issue:
- Screening for Dihydropyrimidine Dehydrogenase (DPD) Deficiency in Fluorouracil Patients: Why Not?
- Sidebar: Why not screen for dihydropyrimidine dehydrogenase (DPD) deficiency in patients receiving fluorouracil or capecitabine? (Letter from the NCCN [National Comprehensive Cancer Network])
- Patient administration errors with the use of alprostadil urethral inserts
- Improved safety needed for pediatric pegfilgrastim use